1 |
98% dehydrated alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 1件: 298 💬 |
2 |
A04ad10 |
- |
- |
- |
- |
298 1件: 298 💬 |
3 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
4 |
Acetyl-l-carnitine |
Acetylcarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 1件: 298 💬 |
5 |
Acetyl-l-carnitine 1000mg 2x per day for 3 months |
Acetylcarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 1件: 298 💬 |
6 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
7 |
Alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
006 4件: 6 , 13, 298, 299 💬 |
8 |
Alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 4件: 13, 58, 279, 298 💬 |
9 |
Alpha 1-antitrypsin |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 2件: 231, 298 💬 |
10 |
Amino acids |
Amino acids |
- |
- |
- |
070 3件: 70, 240, 298 💬 |
11 |
Amlodipine |
Amlodipine |
3件: D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 67, 298 💬 |
12 |
Amlodipine (drug) |
Amlodipine |
3件: D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
298 1件: 298 💬 |
13 |
Analgesics |
- |
- |
- |
- |
298 1件: 298 💬 |
14 |
Antioxidant plus pregabalin |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
298 1件: 298 💬 |
15 |
Antioxidants |
- |
- |
- |
- |
090 3件: 90, 298, 310 💬 |
16 |
Antox |
- |
- |
- |
- |
298 1件: 298 💬 |
17 |
Antox (vers) 1.2 |
- |
- |
- |
- |
298 1件: 298 💬 |
18 |
Antox (vers.)1.2 |
- |
- |
- |
- |
298 1件: 298 💬 |
19 |
Antox version 1.2 |
- |
- |
- |
- |
298 1件: 298 💬 |
20 |
Ascorbic acid |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
010 4件: 10, 97, 206, 298 💬 |
21 |
Autologous mesenchymal stromal cell |
- |
- |
- |
- |
096 2件: 96, 298 💬 |
22 |
Behavioral: smoking and alcohol assumption |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 1件: 298 💬 |
23 |
Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala) |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
298 1件: 298 💬 |
24 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
25 |
Bupivicaine alone |
- |
- |
- |
- |
298 1件: 298 💬 |
26 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
27 |
Calcium, dietary |
Calcium |
- |
- |
- |
298 1件: 298 💬 |
28 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
29 |
Carbon monoxide |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
085 3件: 85, 86, 298 💬 |
30 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
31 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
32 |
Creon |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
33 |
Creon 10000 |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
34 |
Creon 25000 |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
35 |
Creon36™ |
- |
- |
- |
- |
298 1件: 298 💬 |
36 |
Device: mayo interactive breath hold monitor |
Methamidophos |
- |
- |
- |
298 2件: 298, 300 💬 |
37 |
Diagnostic test: genetic sequencing |
- |
- |
- |
- |
298 1件: 298 💬 |
38 |
Diagnostic test: hemoglobin a1c |
Hemoglobin |
- |
- |
- |
298 1件: 298 💬 |
39 |
Diagnostic test: mixed meal tolerance test |
- |
- |
- |
- |
298 1件: 298 💬 |
40 |
Diagnostic test: other exploratory blood biomarkers |
- |
- |
- |
- |
298 1件: 298 💬 |
41 |
Diazepam |
Diazepam |
1件: D00293 D00293 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 3件: 46, 155, 298 💬 |
42 |
Dronabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 5件: 2 , 13, 46, 271, 298 💬 |
43 |
Ensure surgical |
- |
- |
- |
- |
298 1件: 298 💬 |
44 |
Ercp with bupivacaine infusion |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
298 1件: 298 💬 |
45 |
Esomeprazole |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 6件: 13, 46, 86, 98, 298, 299 💬 |
46 |
Etanercept |
Etanercept |
1件: D00742 D00742 💬 |
LTA 2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 14件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
47 |
Eur-1008 (apt-1008) high dose |
- |
- |
- |
- |
298 1件: 298 💬 |
48 |
Eur-1008 (apt-1008) low dose |
- |
- |
- |
- |
298 1件: 298 💬 |
49 |
Eur-1066-a |
- |
- |
- |
- |
298 1件: 298 💬 |
50 |
Eur-1066-b |
- |
- |
- |
- |
298 1件: 298 💬 |
51 |
Eus procedure with drug injection |
- |
- |
- |
- |
298 1件: 298 💬 |
52 |
Fluimucil |
- |
- |
- |
- |
085 4件: 85, 94, 193, 298 💬 |
53 |
Fluimucil*20cpr eff 600mg |
- |
- |
- |
- |
094 2件: 94, 298 💬 |
54 |
Gabapentin |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
55 |
Gabapentin prescriptions |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 1件: 298 💬 |
56 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
57 |
Helopanflat mono® |
- |
- |
- |
- |
298 1件: 298 💬 |
58 |
Hemoglobin |
Hemoglobin |
- |
- |
- |
298 1件: 298 💬 |
59 |
Human secretin |
Secretin human |
- |
- |
- |
298 1件: 298 💬 |
60 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
61 |
Indomethacin |
Indomethacin |
3件: D00141 D00141, D01565 D01565, D02110 D02110 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
225 3件: 225, 271, 298 💬 |
62 |
Intra plexus triamcinolone and bupivicaine injection |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
298 1件: 298 💬 |
63 |
Kreon 25000 |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
64 |
L-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 6件: 13, 96, 97, 265, 298, 316 💬 |
65 |
Lannacher |
- |
- |
- |
- |
298 1件: 298 💬 |
66 |
Lanreotide |
Lanreotide |
1件: D04666 D04666 💬 |
- |
- |
067 4件: 67, 73, 85, 298 💬 |
67 |
Lanreotide acetate |
Acetate |
1件: D04666 D04666 💬 |
- |
- |
067 4件: 67, 73, 85, 298 💬 |
68 |
Lipase |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
69 |
Liprotamase |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
70 |
Lyrica |
- |
- |
- |
- |
298 1件: 298 💬 |
71 |
Lyrica® |
- |
- |
- |
- |
298 1件: 298 💬 |
72 |
Magnesiocard 2.5mmol |
- |
- |
- |
- |
298 1件: 298 💬 |
73 |
Magnesium |
Magnesium |
- |
- |
- |
006 16件: 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
74 |
Magnesium aspartate |
Magnesium |
1件: D02026 D02026 💬 |
- |
- |
298 1件: 298 💬 |
75 |
Magnesium aspartate hydrochloride |
Magnesium |
1件: D02026 D02026 💬 |
- |
- |
298 1件: 298 💬 |
76 |
Methionine |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
034 7件: 34, 75, 84, 93, 229, 298, 300 💬 |
77 |
Mezym f |
- |
- |
- |
- |
298 1件: 298 💬 |
78 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
79 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
80 |
Ms1819 |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
81 |
Ms1819-sd |
MS-1819 |
- |
- |
- |
298 2件: 298, 299 💬 |
82 |
Multienzymes (lipase, protease etc.) |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
83 |
Namisol |
- |
- |
- |
- |
013 2件: 13, 298 💬 |
84 |
Nexium (esomeprazole magnesium) |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
298 1件: 298 💬 |
85 |
Ni-03 |
- |
- |
- |
- |
298 1件: 298 💬 |
86 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
87 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
298 1件: 298 💬 |
88 |
Other: eus procedure |
- |
- |
- |
- |
298 1件: 298 💬 |
89 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
90 |
Other: low-intensity exercise therapy |
- |
- |
- |
- |
298 1件: 298 💬 |
91 |
Other: no enzyme therapy |
- |
- |
- |
- |
298 1件: 298 💬 |
92 |
Other: nutrition counseling |
- |
- |
- |
- |
298 1件: 298 💬 |
93 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 5件: 34, 36, 51, 96, 298 💬 |
94 |
Other: questionnaire administration |
- |
- |
- |
- |
016 4件: 16, 34, 51, 298 💬 |
95 |
Oxycodone |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 7件: 6 , 13, 46, 70, 226, 231, 298 💬 |
96 |
Oxycodone depot ”sandoz”, depot tablets |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
298 1件: 298 💬 |
97 |
Oxycodone hydrochloride |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 4件: 6 , 70, 226, 298 💬 |
98 |
Oxycodonhydrochlorid ”lannacher”, depot tablets |
- |
- |
- |
- |
298 1件: 298 💬 |
99 |
Oxynorm |
- |
- |
- |
- |
298 1件: 298 💬 |
100 |
Pancreatic enzymes |
- |
- |
- |
- |
298 1件: 298 💬 |
101 |
Pancreatin |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 2件: 298, 299 💬 |
102 |
Pancrelipase |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 2件: 298, 299 💬 |
103 |
Pancrelipase delayed release capsule |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 2件: 298, 299 💬 |
104 |
Pancrelipase/pancreas powder |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 2件: 298, 299 💬 |
105 |
Panzytrat |
- |
- |
- |
- |
298 1件: 298 💬 |
106 |
Panzytrat 25.000 |
- |
- |
- |
- |
298 1件: 298 💬 |
107 |
Panzytrat 25.000 fip-e units of lipase |
- |
- |
- |
- |
298 1件: 298 💬 |
108 |
Pentoxifylline |
Pentoxifylline |
1件: D00501 D00501 💬 |
- |
- |
026 10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
109 |
Perflubutane |
Perflubutane |
1件: D05440 D05440 💬 |
- |
- |
298 2件: 298, 300 💬 |
110 |
Pfd |
- |
- |
- |
- |
051 2件: 51, 298 💬 |
111 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
112 |
Pl 00512/0150 |
- |
- |
- |
- |
298 1件: 298 💬 |
113 |
Pregabalin |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 5件: 13, 36, 46, 70, 298 💬 |
114 |
Procedure: celiac block with triamcinolone and bupivicaine |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
298 1件: 298 💬 |
115 |
Procedure: endoscopic drainage of the main pancreatic duct |
- |
- |
- |
- |
298 1件: 298 💬 |
116 |
Procedure: extracorporeal shock wave lithotripsy |
- |
- |
- |
- |
298 1件: 298 💬 |
117 |
Procedure: no celiac block |
- |
- |
- |
- |
298 1件: 298 💬 |
118 |
Prolastin |
- |
- |
- |
- |
231 3件: 231, 298, 299 💬 |
119 |
Prolastin-c |
- |
- |
- |
- |
231 2件: 231, 298 💬 |
120 |
Proton pump inhibitor (ppi) |
- |
- |
- |
- |
298 1件: 298 💬 |
121 |
Radiation: uv-filtered light. |
- |
- |
- |
- |
298 1件: 298 💬 |
122 |
Radiation: uvb |
- |
- |
- |
- |
298 1件: 298 💬 |
123 |
Recombinant microbial lipase |
- |
- |
- |
- |
298 1件: 298 💬 |
124 |
Recombinant microbial lipase slv339 |
- |
- |
- |
- |
298 1件: 298 💬 |
125 |
Regn475/sar164877 |
- |
- |
- |
- |
298 1件: 298 💬 |
126 |
Reparixin |
Reparixin |
1件: D08984 D08984 💬 |
CXCR1 2件: CXCR1, CXCR2 💬 |
Chemokine signaling pathway 7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor |
298 2件: 298, 299 💬 |
127 |
Rg1068 (synthetic human secretin) |
Secretin human |
- |
- |
- |
298 1件: 298 💬 |
128 |
Rvg 13760 |
- |
- |
- |
- |
298 1件: 298 💬 |
129 |
S-ketamin |
- |
- |
- |
- |
298 1件: 298 💬 |
130 |
Sa |
- |
- |
- |
- |
006 5件: 6 , 30, 60, 118, 298 💬 |
131 |
Sa-001 |
- |
- |
- |
- |
298 1件: 298 💬 |
132 |
Secretin |
Secretin human |
- |
- |
- |
298 1件: 298 💬 |
133 |
Selenium |
Selenium |
- |
- |
- |
013 3件: 13, 278, 298 💬 |
134 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
135 |
Slv339 |
- |
- |
- |
- |
298 1件: 298 💬 |
136 |
Somatuline |
- |
- |
- |
- |
067 2件: 67, 298 💬 |
137 |
Somatuline autogel 90 mg |
- |
- |
- |
- |
298 1件: 298 💬 |
138 |
Soy bread |
- |
- |
- |
- |
298 1件: 298 💬 |
139 |
Synthetic human secretin |
Secretin human |
- |
- |
- |
298 1件: 298 💬 |
140 |
Tanezumab |
Tanezumab |
1件: D09387 D09387 💬 |
NGF 1件: NGF 💬 |
Apoptosis 9件: Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
226 2件: 226, 298 💬 |
141 |
Tetrahydro-6,6,9-tri methyl-3-penthyl-6 h-dibenzo[ b,d ]pyran-1-ol |
- |
- |
- |
- |
298 1件: 298 💬 |
142 |
Tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 3件: 8 , 13, 298 💬 |
143 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
144 |
Tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 5件: 13, 49, 206, 257, 298 💬 |
145 |
Triamcinolone |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬 |
146 |
Tyr |
- |
- |
- |
- |
075 2件: 75, 298 💬 |
147 |
Viokase 16 |
- |
- |
- |
- |
298 1件: 298 💬 |
148 |
Viokase 16 (pancrelipase) + nexium |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 1件: 298 💬 |
149 |
Viokase® 16 |
- |
- |
- |
- |
298 1件: 298 💬 |
150 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
151 |
Vitamin d 100ug |
Vitamin D |
- |
- |
- |
298 1件: 298 💬 |
152 |
Vitamin d 10ug |
Vitamin D |
- |
- |
- |
298 1件: 298 💬 |
153 |
Yarrowia lipolytica lipase |
- |
- |
- |
- |
298 1件: 298 💬 |
154 |
Zenpep |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
155 |
Zentase |
- |
- |
- |
- |
298 1件: 298 💬 |